SCHEMBL30310477

SCHEMBL30310477

O=C(O)c1cc2ccc(Cl)c(F)c2[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4A3 P38919 3/20 0.61
HPGD P15428 3/20 0.53
HSD17B10 Q99714 3/20 0.53
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 1/20 0.53
USP2 O75604 1/20 0.53
KMT2A Q03164 1/20 0.53
APEX1 P27695 2/20 0.46
KDM4E B2RXH2 2/20 0.46
F7 P08709 1/20 0.46
F3 P13726 1/20 0.46
PDPK1 O15530 1/20 0.46
LMNA P02545 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
CYP2C19 P33261 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GPR17 Q13304 1/20 0.46
DAO P14920 3/20 0.45
IDO1 P14902 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7677228 1.00 EIF4A3 (0.61) EIF4A3HPGDHSD17B10ALDH1A1MEN1
SCHEMBL29425105 0.83 EIF4A3 (0.65) EIF4A3HPGDHSD17B10ALDH1A1MEN1
SCHEMBL22395050 0.83 EIF4A3 (0.65) EIF4A3HPGDHSD17B10ALDH1A1MEN1
SCHEMBL15515566 0.83 HPGD (0.56) EIF4A3HPGDHSD17B10ALDH1A1MEN1
SCHEMBL30310723 0.81 XDH (0.47) EIF4A3MAPT
SCHEMBL7673791 0.81 XDH (0.47) EIF4A3MAPT
SCHEMBL21225612 0.81 EIF4A3 (0.51) EIF4A3HPGDHSD17B10ALDH1A1MEN1
SCHEMBL27523308 0.81 EIF4A3 (0.68) EIF4A3HPGDHSD17B10ALDH1A1MEN1
SCHEMBL8959651 0.80 EIF4A3 (0.54) EIF4A3HPGDHSD17B10ALDH1A1MEN1
SCHEMBL3605104 0.80 HPGD (0.53) EIF4A3HPGDHSD17B10ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587433-A1 3-(1H-INDOLE-2-CARBONYL)-6,6-DIMETHYL-N-((S)-1-OXO-3-((S)-2-OXOPYRROLIDIN-3-YL)P ROPAN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE DERIVATIVES AS MPRO INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS Takeda Pharmaceutical Company Limited (JP) 2025-07-23 EP disclosed
WO-2024059087-A1 3-(1H-INDOLE-2-CARBONYL)-6,6-DIMETHYL-N-((S)-1-OXO-3-((S)-2-OXOPYRROLIDIN-3-YL)P ROPAN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE DERIVATIVES AS MPRO INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-03-21 WO disclosed
EP-4161902-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2023-04-12 EP disclosed